Iterum Therapeutics Reports Second Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Iterum Therapeutics Plc (ITRM) Tops Q2 EPS by 2c
August 12, 2022 7:07 AM EDTIterum Therapeutics Plc (NASDAQ: ITRM) reported Q2 EPS of ($0.04), $0.02 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.
... More
